In contrast, although moderate therapeutic effects were observed with anti-PD-1 Abs as compared to those with Ova55 peptides, no significant improvement of tumour regression was observed in comparison to that observed with anti–PD-L1 Abs. This evidence concerns the gene CD274 and neoplasm.